Form D · Biotechnology

BIOINCEPT LLC

New York, NY · CIK 0001401750

Offering snapshot reported Oct 20, 2020 · SEC filing

Reported sold
$3.1M
Offering amount: $15M
Investors reported
28
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 30, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 20, 2020Initial$3,100,000No comparison28SEC filing
Mar 7, 2019Initial$2,019,100No comparison17SEC filing
Dec 1, 2016Amendment$7,284,757No comparison38SEC filing
Sep 2, 2016InitialYet to sellNo comparison0SEC filing
Apr 28, 2014Amendment$3,185,000$1,340,000vs Aug 27, 201339SEC filing
Aug 27, 2013Initial$1,845,000No comparison31SEC filing
May 25, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Debt
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-378319

Source: Form D, filed Oct 20, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Eytan R Barnea Director
Jacqueline H Barnea Director
Julia D Corelli Director
David R Duncan Director
Brian Foster Executive
George W. Frank Director
George W Frank, Jr. Director
Barton O'brien Director
Dennis Spink Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
C/O Wework 575 5 Th Avenue Suite 15 103
New York, NY, 10017